Zoetis Inc. – Consensus Indicates Potential 28.8% Upside

Broker Ratings

Zoetis Inc. with ticker code (ZTS) have now 12 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 260 and 180 calculating the average target price we see 215.75. Given that the stocks previous close was at 167.49 this now indicates there is a potential upside of 28.8%. The day 50 moving average is 162.69 while the 200 day moving average is 160.25. The company has a market cap of $74,851m. Company Website: https://www.zoetis.com

The potential market cap would be $96,418m based on the market concensus.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides testing and analysis of blood, urine, and other animal samples and related products and services, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Find more news, interviews, share price & company profile here for:

    Good news travels fast (but only if you make that happen). Share on:

    Forum friendly shortlink: https://1lo.co/nBVT8

      AIM All Share Index